Skip to main content

PERCEPTIVE ADVISORS LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1224962 NEW YORK, NY

Position in APLS

as of Mar 31, 2026 · filed May 29, 2026
Position Value
$0
+$0 QoQ
Shares Held
80,956
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Sep 30, 2023
CallValue
$0
CallShares
0
PutValue
$0
PutShares
100,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PERCEPTIVE ADVISORS LLC holds $5,486,611,234 across 68 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 80,956
2023-09-30 100,000
2023-06-30 812,037
2023-03-31 555,344
2022-09-30 366,400
2022-06-30 321,300
2022-03-31 1,481,700
2021-12-31 1,451,700
2021-09-30 615,000
2021-06-30 661,162
2020-06-30 11,418
2020-03-31 11,418